Free Trial

Acutus Medical Q2 2024 Earnings Report

Acutus Medical logo
$0.05 0.00 (-7.59%)
As of 02/21/2025 03:54 PM Eastern

Acutus Medical EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Acutus Medical Revenue Results

Actual Revenue
$4.13 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Acutus Medical Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Acutus Medical Earnings Headlines

Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
See More Acutus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Acutus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acutus Medical and other key companies, straight to your email.

About Acutus Medical

Acutus Medical (NASDAQ:AFIB) designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

View Acutus Medical Profile

More Earnings Resources from MarketBeat